Growth inhibition of a tongue squamous cell carcinoma cell line (Tca8113) in vitro and in vivo via siRNA-mediated down-regulation of skp2

International Journal of Oral and Maxillofacial Surgery

Volumn 37, Issue 9, 2008, Pages 847-852

  Fang, Liang ^a   Hu, Qingang ^a   Hua, Zichun ^b   Li, Shufeng ^b   Dong, Wei ^c  

^a Jiangsu Province Engineering Research Center of Stomatological Translational Medicine   (China)

^b NANJING UNIVERSITY   (China)

^c NANJING UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

gene therapy; p27Kip1; RNA interference; skp2; Tca8113 cells; tongue squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; PLASMID VECTOR; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA;

ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; MOUTH CARCINOMA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE SILENCING; HUMANS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; RANDOM ALLOCATION; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS; TONGUE NEOPLASMS;

EID: 52049109418     PISSN: 09015027     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijom.2008.05.017     Document Type: Article

References (25)

1. Brummelkamp T.R., Bernards R., and Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296 (2002) 550-553
2. Carrano A.C., Eytan E., Hershko A., and Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1 (1999) 193-199
3. Chiarle R., Fan Y., Piva R., Boggino H., Skolnik J., Novero D., Palestro G., De Wolf-Peeters C., Chilosi M., Pagano M., and Inghirami G. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase. Am J Pathol 160 (2002) 1457-1466
4. Dong W., Jin G.H., and Li S.F. Cross-linked polyethyenimine as potential DNA for gene delivery with high efficiency and low cytotoxicity. Acta Biochimica et Biophysica Sinica 38 (2006) 780-787
5. Fang L., Hu Q.G., Huang X.F., and Chen X.H. Primary Observation of Expression of p27 and skp2 Proteins in Oral Squamous Cell Carcinoma. J Oral Science Research 22 (2006) 364-367
6. Hershko D., Bornstein G., Ben-Izhak O., Carrano A., Pagano M., Krausz M.M., and Hershko A. Inverse relation between levels of p27Kip1 and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer 91 (2001) 1745-1751
7. Jiang F., Caraway N.P., Li R., and Katz R.L. RNA silencing of S-phase kinase-interacting protein 2 inhibits proliferation and centrosome amplification in lung cancer cells. Oncogene 24 21 (2005) 3409-3418
8. Katagiri Y., Hozumi Y., and Kondo S. Knockdown of skp2 by siRNA inhibits melanoma cell growth in vitro and in vivo. J Dermatological Science 42 (2006) 215-224
9. Kudo Y., Takata T., Yasui W., Ogawa I., Miyauchi M., Takekoshi T., Tahara E., and Nikai H. Reduced expression of cyclin-dependent kinase inhibitor p27 is an indicator of malignant behavior of oral squamous cell carcinomas. Cancer 83 (1998) 2447-2455
10. Kudo Y., Kitajima S., Sato S., Miyauchi M., Ogawa I., and Takata T. High expression of S-phase kinase-interacting protein 2, Human F-box protein, correlates with poor prognosis in Oral squamous cell carcinomas. Cancer Res 61 (2001) 7044-7047
11. Kudo Y., Kitajima S., Sato S., Ogawa I., Miyauchi M., and Takata T. Transfection of p27 Kip1 threonine residue 187 mutant type gene, which is not influenced by ubiquitin-mediated degradation, induces cell cycle arrest in oral squamous cell carcinoma cells. Oncology 63 (2002) 398-404
12. kip1 expression in melanocytic nevi and melanoma: an inverse relationship. J Cutan Pathol 31 (2004) 633-642
13. Li S.F., Dong W., and Zong Y.W. Polyethyenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol Ther 15 (2007) 515-523
14. Masuda T.A., Inoue H., Sonoda H., Mine S., Yoshikawa Y., Nakayama K., Nakayama K., and Mori M. Clinical and biological significance of S-phase kinase-associated protein 2 (skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by skp2 overexpression, possibly via p27 proteolysis. Cancer Res 62 (2000) 3819-3825
15. Pagano M., Tam S.W., Theodoras A.M., Beer-Romero P., Del Sal G., Chau V., Yew P.R., Draetta G.F., and Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269 (1995) 682-685
16. Polyak K., Lee M.H., Erdjument-Bromage H., Koff A., Roberts J.M., Tempst P., and Massagué J. Cloning of p27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 79 (1994) 59-66
17. Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 14 (1961) 1272-1294
18. Shapira M., Ben-Izhak O., Linn S., Futerman B., Minkov I., and Hershko D.D. The prognostic impact of the ubiquitin ligase subunits skp2 and Cks1 in colorectal carcinoma. Cancer 103 (2005) 1336-1346
19. Sharp P.A., and Zamore P.D. Molecular biology. RNA interference. Science 287 (2000) 2431-2433
20. Sherr C.J., and Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9 (1995) 1149-1163
21. Shintani S., Li C., Mihara M., Hino S., Nakashiro K., and Hamakawa H. Skp2 and Jab1 expression are associated with inverse expression of p27 (KIP1) and poor prognosis in oral squamous cell carcinomas. Oncology 65 4 (2003) 355-362
22. Signoretti S., Di Marcotullio L., Richardson A., Ramaswamy S., Isaac B., Rue M., Monti F., Loda M., and Pagano M. Oncogenic role of the ubiquitin ligase subunit skp2 in human breast cancer. J Clin Invest 110 (2002) 633-641
23. Yokoi S., Yasui K., Iizasa T., Takahashi T., Fujisawa T., and Inazawa J. Down-regulation of SKP2 induces apoptosis in lung-cancer cells. Cancer Sci 94 (2003) 344-349
24. Yokoi S., Yasui K., Mori M., Iizasa T., Fujisawa T., and Inazawa J. Amplification and overexpression of skp2 are associated with metastasis of non-small-cell lung caners to lymph nodes. Am J Pathol 165 (2004) 175-180
25. Wei W., Ayad N.G., Wan Y., Zhang G.J., Kirschner M.W., and Kaelin Jr. W.G. Degradation of the SCF component skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428 (2004) 194-198